Global Peptide Antibiotics Market Report 2022: Sector to Reach $5.74 Billion in 2026 at a CAGR of 8%

DUBLIN, March 27, 2023 /PRNewswire/ -- The "Peptide Antibiotics Global Market Report 2022: Ukraine-Russia War Impact" report has been added to  ResearchAndMarkets.com's offering.

This provides strategists, marketers and senior management with the critical information they need to assess the global peptide antibiotics market.

The global peptide antibiotics market is expected to grow from $3.95 billion in 2021 to $4.22 billion in 2022 at a compound annual growth rate (CAGR) of 6.97%. The peptide antibiotics market is expected to reach $5.74 billion in 2026 at a CAGR of 8.00%. 

Major players in the peptide antibiotics market are Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Theravance Biopharma, Pacgen Life Science Corporation, Kasten, Savara Pharmaceuticals, Merck KGaA, Madam Therapeutics, Allergan Plc, Dr. Reddy's Laboratories Ltd, Sanofi, Fresenius Kabi AG, Novo Holdings A/S and Teva Pharmaceutical Industries Ltd.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Assessment of Russia - War Impact on agriculture, energy and mineral commodities supply and their direct and indirect impact on the market analyzed in the report.
• Impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The peptide antibiotics market consists of sales of oral, intravenous, intramuscular and topical peptide antibiotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.

North America was the largest region in the peptide antibiotics market in 2021. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

The main types of peptide antibiotics are ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics. The ribosomal synthesized peptide antibiotics destroy or modify the drug, change the drug target, decrease or raise drug uptake, and substitute a different metabolic step as the medication's target. Ribosomal synthesized peptide antibiotics refer to antimicrobial peptides generated by ribosomes and produced by practically all species, from bacteria to plants and animals.

The various drugs under peptide antibiotics are daptomycin, dalbavancin, telavancin, and other drugs used to treat several diseases such as skin infection, HABP/VABP, blood stream infection, and other diseases. The peptide antibiotics are used and distributed through hospitals, homecare, specialty clinics, and other distribution channels.

The increase in the prevalence of various infectious diseases is expected to propel the growth of the peptide antibiotics market. Infectious diseases are illnesses caused by harmful micro-organisms such as bacteria, fungi, parasites, and others.

The major reasons for the rise in infectious diseases are rapid urbanization, climate change, increasing risk of disease emergence, and others, which have increased the demand for peptide antibiotics. Peptide antibiotics physically rupture the cell membranes and underpins the antibacterial activity. 

The strategic partnership is a key trend gaining popularity in the peptide antibiotics market. Major companies operating in the peptide antibiotics market are entering into partnerships to expand their market and leverage each others resources.

For instance, in January 2022, Berkeley Lights, a US-based digital cell biology company, partnered with Aanika Biosciences. In this partnership, Aanika will leverage Berkeley Lights' high-throughput, functional screening service to swiftly find and refine functional antimicrobial peptides (AMPs) capable of eliminating dangerous bacteria, particularly those that cause foodborne disease outbreaks.

Furthermore, the Beacon Optofluidic Platform will be used to identify peptides that are harmful to bacteria in order to develop a novel antibacterial tag, which will then be used in their bacterial spore-based barcoding technology to secure the food supply chain. Aanika Biosciences is a US-based biotechnology company.

An increase in incidence of chronic diseases is expected to drive the peptide antibiotics market. Chronic diseases are illnesses that last a year or longer, demand ongoing medical attention, and limit daily activities. Chronic diseases are on the rise as a result of increased tobacco use, poor nutrition, physical inactivity, excessive alcohol consumption, and other factors. Peptide antibiotics are used to treat chronic diseases by administering the drug in the target area. 

The countries covered in the peptide antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Key Topics Covered:

1. Executive Summary

2. Peptide Antibiotics Market Characteristics

3. Peptide Antibiotics Market Trends And Strategies

4. Peptide Antibiotics Market - Macro Economic Scenario
4.1. COVID-19 Impact On Peptide Antibiotics Market
4.2. Ukraine-Russia War Impact On Peptide Antibiotics Market
4.3. Impact Of High Inflation On Peptide Antibiotics Market

5. Peptide Antibiotics Market Size And Growth
5.1. Global Peptide Antibiotics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Peptide Antibiotics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Peptide Antibiotics Market Segmentation
6.1. Global Peptide Antibiotics Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Ribosomal Synthesized Peptide Antibiotics
• Non-rRibosomal Synthesized Peptide Antibiotics

6.2. Global Peptide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Daptomycin
• Dalbavancin
• Telavancin
• Other Drugs

6.3. Global Peptide Antibiotics Market, Segmentation By Disease Outlook, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Skin Infection
• HABP/VABP
• Blood Stream Infection
• Other Diseases

6.4. Global Peptide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

• Hospitals
• Homecare
• Specialty Clinics
• Other Distribution Channels

7. Peptide Antibiotics Market Regional And Country Analysis
7.1. Global Peptide Antibiotics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Peptide Antibiotics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

For more information about this report visit https://www.researchandmarkets.com/r/owqeha

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716 

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg 

SOURCE Research and Markets